Notice: This company has been marked as potentially delisted and may not be actively trading. Icosavax (ICVX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Assembly Biosciences (NASDAQ:ASMB) Stock Quotes, Forecast and News SummarySeptember 24, 2024 | benzinga.comFrazier Life Sciences Adds Industry Veteran and Serial Dealmaker, Adam Simpson, to Company Creation TeamSeptember 20, 2024 | finance.yahoo.comVaxcyte Inc Ordinary Shares 5VAAugust 2, 2024 | morningstar.comNervGen Pharma Corp Ordinary Shares NGENApril 21, 2024 | morningstar.comCHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)March 20, 2024 | markets.businessinsider.comTrading was temporarily halted for "ICVX" at 07:02 PM with a stated reason of "News pending."February 19, 2024 | marketbeat.comIcosavax, Inc. (NASDAQ:ICVX) Shares Bought by Barclays PLCBarclays PLC grew its holdings in Icosavax, Inc. (NASDAQ:ICVX - Free Report) by 3,589.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 202,182 shares of the company's stock after purchasing an additional 196,702 shareFebruary 17, 2024 | marketbeat.comIcosavax: Tender Offer With Contingent Value RightFebruary 11, 2024 | seekingalpha.comIcosavax, Inc. (NASDAQ:ICVX) CEO Sells $229,350.00 in StockIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) CEO Adam K. Simpson sold 15,000 shares of the company's stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $15.29, for a total transaction of $229,350.00. Following the transaction, the chief executive officer now directly owns 358,657 shares of the company's stock, valued at approximately $5,483,865.53. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.February 2, 2024 | marketbeat.comIcosavax CVR Seems Fairly ValuedJanuary 5, 2024 | seekingalpha.comAdam K. Simpson Sells 15,000 Shares of Icosavax, Inc. (NASDAQ:ICVX) StockIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) CEO Adam K. Simpson sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $15.67, for a total transaction of $235,050.00. Following the completion of the sale, the chief executive officer now directly owns 260,641 shares of the company's stock, valued at approximately $4,084,244.47. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.January 4, 2024 | marketbeat.comGuggenheim Downgrades Icosavax (ICVX)January 2, 2024 | msn.comIcosavax's (ICVX) "Neutral" Rating Reiterated at GuggenheimGuggenheim reissued a "neutral" rating on shares of Icosavax in a research note on Tuesday.January 2, 2024 | marketbeat.comICOSAVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Icosavax, Inc. - ICVXDecember 31, 2023 | businesswire.comChief Medical Officer Niranjan Kanesa-thasan Sells 11,884 Shares of Icosavax Inc (ICVX)December 24, 2023 | finance.yahoo.comInsider Selling: Icosavax, Inc. (NASDAQ:ICVX) Insider Sells 11,884 Shares of StockIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) insider Niranjan Kanesa-Thasan sold 11,884 shares of the business's stock in a transaction on Wednesday, December 20th. The shares were sold at an average price of $15.46, for a total value of $183,726.64. Following the completion of the transaction, the insider now owns 223,980 shares of the company's stock, valued at $3,462,730.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.December 22, 2023 | marketbeat.comICVX Jul 2024 15.000 callDecember 18, 2023 | ca.finance.yahoo.comIcosavax, Inc. (NASDAQ:ICVX) Short Interest Down 5.6% in NovemberIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) saw a significant decrease in short interest in November. As of November 30th, there was short interest totalling 1,680,000 shares, a decrease of 5.6% from the November 15th total of 1,780,000 shares. Approximately 5.2% of the company's shares are sold short. Based on an average daily volume of 317,300 shares, the short-interest ratio is presently 5.3 days.December 18, 2023 | marketbeat.comInsider Sell Alert: Chief Business Officer Cassia Cearley Sells 8,759 Shares of Icosavax Inc (ICVX)December 16, 2023 | finance.yahoo.comCassia Cearley Sells 8,759 Shares of Icosavax, Inc. (NASDAQ:ICVX) StockIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) insider Cassia Cearley sold 8,759 shares of the stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $16.01, for a total value of $140,231.59. Following the sale, the insider now owns 131,200 shares of the company's stock, valued at $2,100,512. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.December 15, 2023 | marketbeat.comIcosavax (NASDAQ:ICVX) Downgraded by William BlairWilliam Blair cut shares of Icosavax from an "outperform" rating to a "market perform" rating in a research note on Tuesday.December 14, 2023 | marketbeat.comIcosavax, Inc. (ICVX) Is Up 0.10% in One Week: What You Should KnowDecember 13, 2023 | finance.yahoo.comIcosavax, Inc. (ICVX) Moves to Buy: Rationale Behind the UpgradeDecember 13, 2023 | finance.yahoo.comIcosavax just downgraded at Jefferies, here's whyDecember 12, 2023 | realmoney.thestreet.comIcosavax deal CVR based on FDA approval for IVX-A12, sales in EU, UK, CanadaDecember 12, 2023 | msn.comIcosavax just downgraded at William Blair, here's whyDecember 12, 2023 | realmoney.thestreet.comShareholder Alert: Ademi LLP investigates whether Icosavax, Inc. has obtained a Fair Price in its transaction with AstraZenecaDecember 12, 2023 | stockhouse.comICVX STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Icosavax, Inc. Is Fair to ShareholdersDecember 12, 2023 | tmcnet.comWhy Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketDecember 12, 2023 | markets.businessinsider.comAstraZeneca to acquire vaccine maker Icosavax in ~$1.1B dealDecember 12, 2023 | msn.comIcosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older AdultsDecember 12, 2023 | finance.yahoo.comIcosavax, Inc. Announces Agreement to be Acquired by AstraZenecaDecember 12, 2023 | finance.yahoo.comWall Street Analysts Believe Icosavax, Inc. (ICVX) Could Rally 175.87%: Here's is How to TradeDecember 8, 2023 | finance.yahoo.comIcosavax, Inc. (ICVX) is on the Move, Here's Why the Trend Could be SustainableDecember 4, 2023 | finance.yahoo.comIcosavax (ICVX) Price Target Increased by 5.00% to 24.99November 27, 2023 | msn.comGuggenheim Initiates Coverage of Icosavax (ICVX) with Buy RecommendationNovember 18, 2023 | msn.comIcosavax initiated with a Buy at GuggenheimNovember 17, 2023 | realmoney.thestreet.comTD Cowen Keeps Their Buy Rating on Icosavax (ICVX)November 16, 2023 | markets.businessinsider.comTarget Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On WednesdayNovember 15, 2023 | markets.businessinsider.comIcosavax, Inc.: Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 15, 2023 | finanznachrichten.deIcosavax Inc (ICVX) Reports Q3 2023 Financial Results and Corporate ProgressNovember 14, 2023 | finance.yahoo.comIcosavax Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 14, 2023 | finance.yahoo.comAura Biosciences GAAP EPS of -$0.48November 10, 2023 | seekingalpha.comIcosavax to Participate in the Jefferies London Healthcare ConferenceNovember 8, 2023 | finance.yahoo.comIcosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) ConferenceOctober 31, 2023 | finance.yahoo.comWe're Not Very Worried About Icosavax's (NASDAQ:ICVX) Cash Burn RateOctober 30, 2023 | finance.yahoo.comIcosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023September 19, 2023 | finance.yahoo.comTower Research Capital LLC TRC Acquires 20,910 Shares of Icosavax, Inc. (NASDAQ:ICVX)Tower Research Capital LLC TRC increased its stake in shares of Icosavax, Inc. (NASDAQ:ICVX - Free Report) by 1,516.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,289 shares of the company's stock after acquiring aSeptember 1, 2023 | marketbeat.comJefferies Reaffirms Their Buy Rating on Icosavax (ICVX)August 15, 2023 | markets.businessinsider.comIcosavax Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 14, 2023 | finance.yahoo.com Get Icosavax News Delivered to You Automatically Sign up to receive the latest news and ratings for ICVX and its competitors with MarketBeat's FREE daily newsletter. Email Address “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in… >> YES! Send Me My FREE Gold Guide! ICVX Media Mentions By Week ICVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ICVX News Sentiment▼0.000.56▲Average Medical News Sentiment ICVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ICVX Articles This Week▼00▲ICVX Articles Average Week Get Icosavax News Delivered to You Automatically Sign up to receive the latest news and ratings for ICVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Stoke Therapeutics News Monte Rosa Therapeutics News Seres Therapeutics News Invivyd News bluebird bio News Kronos Bio News LianBio News PHAXIAM Therapeutics News Alpha Tau Medical News BriaCell Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ICVX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icosavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Icosavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
